KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Herbalife (HLF) Gains from Investment Securities (2016 - 2025)

Herbalife's Gains from Investment Securities history spans 17 years, with the latest figure at -$1.6 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 147.06% year-over-year to -$1.6 million; the TTM value through Sep 2025 reached $8.5 million, up 193.1%, while the annual FY2024 figure was $7.9 million, 108.22% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was -$1.6 million at Herbalife, down from $2.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $7.3 million in Q4 2024 and bottomed at -$8.9 million in Q3 2022.
  • The 5-year median for Gains from Investment Securities is $2.3 million (2023), against an average of $1.0 million.
  • The largest annual shift saw Gains from Investment Securities crashed 302.27% in 2022 before it soared 600.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$4.7 million in 2021, then soared by 169.0% to $3.2 million in 2022, then increased by 16.99% to $3.8 million in 2023, then skyrocketed by 92.41% to $7.3 million in 2024, then plummeted by 121.92% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for HLF's Gains from Investment Securities are -$1.6 million (Q3 2025), $2.3 million (Q2 2025), and $500000.0 (Q1 2025).